TIME TO REBOUND IN JOINT SYMPTOMS FOLLOWING DISCONTINUATION OF TNFI THERAPY AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PSORIATIC ARTHRITIS PATIENTS ENROLLED IN THE US CORRONA REGISTRY

被引：0
|
作者：
Harrold, L. R. [1 ]
Stolshek, B. [2 ]
Rebello, S. [1 ]
Collier, D. [2 ]
Mutebi, A. [2 ]
Wade, S. W. [3 ]
Malley, W. [1 ]
Greenberg, J. D. [1 ]
Etzel, C. J. [1 ]
机构：
[1] Corrona LLC, Southborough, MA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Wade Outcomes Res Consulting, Salt Lake City, UT USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1324
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0423
引用
收藏
页码：342 / 343
页数：2
相关论文
共 34 条
  • [1] Time to rebound in joint symptoms following discontinuation of TNFi therapy after achieving low disease activity in psoriatic arthritis patients enrolled in the US Corrona Registry
    Harrold, Leslie R.
    Stolshek, Brad
    Rebello, Sabrina
    Collier, David
    Mutebi, Alex
    Wade, Sally W.
    Greenberg, Jeffery D.
    Etzel, Carol J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB260 - AB260
  • [2] Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity
    Harrold, Leslie R.
    Stolshek, Bradley S.
    Rebello, Sabrina
    Collier, David H.
    Mutebi, Alex
    Wade, Sally W.
    Malley, Wendi
    Greenberg, Jeffrey D.
    Etzel, Carol J.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 78 - 82
  • [3] DISCONTINUATION AND SWITCHING PATTERNS OF TUMOUR NECROSIS FACTOR INHIBITOR (TNFI) THERAPY IN TNFI-NAIVE AND TNFI-EXPERIENCED PATIENTS WITH PSORIATIC ARTHRITIS IN THE US CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY
    Mease, P.
    Liu, M.
    Gershenson, B.
    Hur, P.
    Greenberg, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 382 - 382
  • [4] Discontinuation and Switching Patterns By TNFi Line of Therapy in Patients with Psoriatic Arthritis-Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Mease, Philip J.
    Karki, Chitra
    Liu, Mei
    Li, YouFu
    Hur, Peter
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry
    Mease, Philip J.
    Karki, Chitra
    Liu, Mei
    Li, YouFu
    Gershenson, Bernice
    Feng, Hua
    Hur, Peter
    Greenberg, Jeffrey D.
    RMD OPEN, 2019, 5 (01):
  • [6] Persistence in Low Disease Activity or Remission with Etanercept Monotherapy in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Rebello, Sabrina
    Karis, Elaine
    Kricorian, Greg
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Matsubara, Tsukasa
    Yamanaka, Hisashi
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2012, 22 (06) : 814 - 822
  • [8] Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Mease, Philip J.
    van der Heijde, Desiree
    Karki, Chitra
    Liu, Mei
    Park, Yujin
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] PERSISTENCE ON TUMOUR NECROSIS FACTOR INHIBITOR (TNFI) MONOTHERAPY AFTER ACHIEVING REMISSION OR LOW DISEASE ACTIVITY (LDA) ON COMBINATION THERAPY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Pappas, D. A.
    Litman, H. J.
    Lesperance, T.
    Rebello, S.
    Karis, E.
    Kricorian, G.
    Hua, W.
    Accortt, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 600 - 601
  • [10] Discontinuation of Biologics in Patients with Rheumatoid Arthritis after Achieving Low-Activity Disease Status
    Ochiai, Moeko
    Sato, Eri
    Tanaka, Eiichi
    Inoue, Eisuke
    Nakajima, Ayako
    Momohara, Shigeki
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S213 - S214
1234